Novel therapies in models of arthritis and bone loss
The overall objective of this project licence is to identify novel compounds and antibodies that could become new medicines for the treatment of chronic inflammatory diseases such as rheumatoid arthritis and metabolic bone diseases such as osteoporosis.
Date: Tue Aug 29 14:18:16 BST 2006
